CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:CONTX - SE0014731154 - Common Stock
3.93 NOK
+0.11 (+2.88%)
Overall CONTX gets a fundamental rating of 5 out of 10. We evaluated CONTX against 11 industry peers in the Health Care Technology industry. While CONTX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CONTX is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
CONTX had a positive operating cash flow in the past year.
CONTX had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CONTX had a positive operating cash flow.
1.2 Ratios
CONTX has a better Return On Assets (7.66%) than 63.64% of its industry peers.
CONTX has a Return On Equity of 10.25%. This is comparable to the rest of the industry: CONTX outperforms 54.55% of its industry peers.
With a decent Return On Invested Capital value of 8.96%, CONTX is doing good in the industry, outperforming 72.73% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CONTX is significantly above the industry average of 9.17%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(8.96%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
The Profit Margin of CONTX (7.86%) is comparable to the rest of the industry.
CONTX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 9.33%, CONTX is in line with its industry, outperforming 54.55% of the companies in the same industry.
In the last couple of years the Operating Margin of CONTX has grown nicely.
CONTX has a Gross Margin of 97.46%. This is amongst the best in the industry. CONTX outperforms 90.91% of its industry peers.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
Compared to 1 year ago, CONTX has about the same amount of shares outstanding.
The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
The debt/assets ratio for CONTX is higher compared to a year ago.
2.2 Solvency
CONTX has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.49, CONTX is in line with its industry, outperforming 54.55% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that CONTX is not too dependend on debt financing.
The Debt to Equity ratio of CONTX (0.07) is better than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC7.07%
2.3 Liquidity
CONTX has a Current Ratio of 4.12. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
CONTX has a Current ratio of 4.12. This is amongst the best in the industry. CONTX outperforms 90.91% of its industry peers.
A Quick Ratio of 4.07 indicates that CONTX has no problem at all paying its short term obligations.
The Quick ratio of CONTX (4.07) is better than 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
CONTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.32%, which is quite good.
CONTX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 40.02% yearly.
CONTX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.19%.
CONTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.78% yearly.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
3.2 Future
CONTX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.64% yearly.
Based on estimates for the next years, CONTX will show a decrease in Revenue. The Revenue will decrease by -1.19% on average per year.
EPS Next Y-28.88%
EPS Next 2Y-41.42%
EPS Next 3Y-31.69%
EPS Next 5Y-10.64%
Revenue Next Year-5.88%
Revenue Next 2Y-6.15%
Revenue Next 3Y-3.72%
Revenue Next 5Y-1.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.73, the valuation of CONTX can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CONTX indicates a rather cheap valuation: CONTX is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (26.46), we can say CONTX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.73 | ||
| Fwd PE | N/A |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CONTX.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CONTX is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.13 | ||
| EV/EBITDA | 11.17 |
4.3 Compensation for Growth
CONTX has a very decent profitability rating, which may justify a higher PE ratio.
CONTX's earnings are expected to decrease with -31.69% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3Y-31.69%
5. Dividend
5.1 Amount
CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
CONTX's Dividend Yield is rather good when compared to the industry average which is at 3.46. CONTX pays more dividend than 90.91% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, CONTX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-41.42%
EPS Next 3Y-31.69%
OSL:CONTX (12/5/2025, 1:53:28 PM)
3.93
+0.11 (+2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap304.06M
Revenue(TTM)132.19M
Net Income(TTM)9.36M
Analysts40
Price Target4.08 (3.82%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)100%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.73 | ||
| Fwd PE | N/A | ||
| P/S | 2.38 | ||
| P/FCF | 48.13 | ||
| P/OCF | 20.76 | ||
| P/B | 3.1 | ||
| P/tB | 3.2 | ||
| EV/EBITDA | 11.17 |
EPS(TTM)0.45
EY11.45%
EPS(NY)0
Fwd EYN/A
FCF(TTM)0.08
FCFY2.08%
OCF(TTM)0.19
OCFY4.82%
SpS1.65
BVpS1.27
TBVpS1.23
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.58
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC7.07%
ROIC/WACC1.27
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-41.42%
EPS Next 3Y-31.69%
EPS Next 5Y-10.64%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
Revenue Next Year-5.88%
Revenue Next 2Y-6.15%
Revenue Next 3Y-3.72%
Revenue Next 5Y-1.19%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-32.14%
EBIT Next 3Y9.74%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.
What is the valuation status of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a valuation rating of 4 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Fairly Valued.
How profitable is CONTEXTVISION AB (CONTX.OL) stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 7 / 10.
How financially healthy is CONTEXTVISION AB?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.
Can you provide the expected EPS growth for CONTX stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -28.88% in the next year.